Ethic Inc. Purchases 35,352 Shares of The Cooper Companies, Inc. $COO

Ethic Inc. increased its position in The Cooper Companies, Inc. (NASDAQ:COO) by 464.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 42,969 shares of the medical device company’s stock after acquiring an additional 35,352 shares during the quarter. Ethic Inc.’s holdings in Cooper Companies were worth $2,429,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Avalon Trust Co bought a new stake in Cooper Companies during the 2nd quarter valued at approximately $25,000. Elevation Wealth Partners LLC grew its holdings in Cooper Companies by 1,136.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock valued at $29,000 after buying an additional 375 shares during the last quarter. Continuum Advisory LLC bought a new position in Cooper Companies in the 2nd quarter worth approximately $30,000. J.Safra Asset Management Corp bought a new position in Cooper Companies in the 2nd quarter worth approximately $32,000. Finally, Northwestern Mutual Wealth Management Co. bought a new position in Cooper Companies in the 2nd quarter worth approximately $60,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Insider Buying and Selling at Cooper Companies

In related news, Director Walter Rosebrough, Jr. acquired 3,000 shares of the stock in a transaction dated Monday, September 14th. The shares were bought at an average cost of $54.29 per share, for a total transaction of $162,870.00. Following the purchase, the director owned 20,000 shares in the company, valued at approximately $1,085,800. This trade represents a 17.65% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Paul Keel bought 4,701 shares of the company’s stock in a transaction dated Friday, September 11th. The stock was bought at an average cost of $53.18 per share, with a total value of $249,999.18. Following the completion of the acquisition, the director owned 4,701 shares in the company, valued at $249,999.18. This represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have purchased 34,701 shares of company stock valued at $1,880,039. 2.08% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

COO has been the subject of a number of research analyst reports. Piper Sandler reiterated a “neutral” rating on shares of Cooper Companies in a report on Thursday, October 15th. Stifel Nicolaus set a $70.00 price objective on shares of Cooper Companies and gave the stock a “buy” rating in a research note on Thursday, September 10th. Zacks Research lowered shares of Cooper Companies from a “hold” rating to a “strong sell” rating in a research report on Friday, September 11th. Citigroup reiterated a “neutral” rating and set a $60.00 target price (down from $80.00) on shares of Cooper Companies in a research note on Thursday, September 10th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Cooper Companies from $71.00 to $58.00 and set a “neutral” rating for the company in a report on Thursday, September 10th. Four equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, Cooper Companies has an average rating of “Hold” and an average price target of $68.60.

Cooper Companies Stock Performance

Shares of NASDAQ COO opened at $62.93 on Thursday. The business has a fifty day simple moving average of $58.80 and a 200 day simple moving average of $68.33. The company has a current ratio of 1.22, a quick ratio of 0.73 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $11.97 billion, a price-to-earnings ratio of 21.48, a PEG ratio of 2.50 and a beta of 0.83. The Cooper Companies, Inc. has a one year low of $51.01 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.12 by $0.03. The firm had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.10 billion. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. The business’s revenue for the quarter was up .5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.49 EPS. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Sell-side analysts expect that The Cooper Companies, Inc. will post 4.53 EPS for the current year.

Cooper Companies announced that its Board of Directors has authorized a share repurchase plan on Wednesday, September 9th that authorizes the company to buy back $3 billion in shares. This repurchase authorization authorizes the medical device company to purchase up to 22.7% of its shares through open market purchases. Stock repurchase plans are usually an indication that the company’s board believes its stock is undervalued.

Cooper Companies Profile

CooperCompanies is a global medical device company focused on vision care and women’s health. It serves customers in markets around the world through two primary businesses: CooperVision and CooperSurgical. CooperVision develops and sells contact lenses, including products for daily wear, astigmatism, presbyopia and myopia management. Its offerings include lenses made from silicone hydrogel and other materials, as well as specialty lens options. CooperSurgical provides products and services for women’s health and fertility care.